BIOVIA Registration

 

The registration of substances plays a central role in drug discovery. Registration allows you to identify substances by their key characteristics, and track their progress by assigning one or more identifiers or labels.

A consistent approach of registering substances allows organizations to improve their IP capture and protection, internal and external collaboration, leading to R&D efficiency and agility. BIOVIA offers a fully featured, web-based out-of-the-box registration solution for chemicals as well as for biologics with access to a flexible data model that can accommodate almost any entity type. With BIOVIA Registration, you can register both chemicals and biologics in a common platform allowing your organization to take a comprehensive approach to substance management.

Capabilities

Benefits

Knowledge Capture

  • Capture key substance characteristics
  • Identify assets uniquely and unambiguously
  • Track the discovery and development of new and complex therapeutic entities

Knowledge Capture

  • Scientific decision support
  • Protect IP and reduce patent challenge risk
  • Minimize the risk of working on the wrong sample

Improved Data Management Processes

  • Implement consistent processes for all therapeutic entities
  • Minimize manual data curation by automating data correct and validation

Improved Data Management Processes

  • Eliminate data integrity issues
  • Increase efficiency by reducing manual curation

Internal & External Collaboration

  • Use consistent substance representation throughout based on modern industry standards
  • Apply business rules to ensure quality and completeness of data

Internal & External Collaboration

  • Reduce hand off time between teams and individuals
  • Produce reports and dashboards

R&D Agility

  • Speed up the adoption of new types of therapeutic entities
  • Facilitate the integration of external libraries (e.g. after company acquisition)

R&D Agility

  • Produce innovative therapeutics
  • Understand and leverage newly acquired assets